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Entamoeba histolytica, an early branching eukaryote, is
the etiologic agent of amebiasis. Calcium plays a pivotal
role in the pathogenesis of amebiasis by modulating the
cytopathic properties of the parasite. However, the mech-
anistic role of Ca2 and calcium-binding proteins in the
pathogenesis of E. histolytica remains poorly understood.
We had previously characterized a novel calcium-binding
protein (EhCaBP1) from E. histolytica. Here, we report
the identification and partial characterization of an iso-
form of this protein, EhCaBP2. Both EhCaBPs have four
canonical EF-hand Ca2 binding domains. The two iso-
forms are encoded by genes of the same size (402 bp).
Comparison between the two genes showed an overall
identity of 79% at the nucleotide sequence level. This iden-
tity dropped to 40% in the 75-nucleotide central linker
region between the second and third Ca2 binding do-
mains. Both of these genes are single copy, as revealed by
Southern hybridization. Analysis of the available E. his-
tolytica genome sequence data suggested that the two
genes are non-allelic. Homology-based structural model-
ing showed that the major differences between the two
EhCaBPs lie in the central linker region, normally in-
volved in binding target molecules. A number of studies
indicated that EhCaBP1 and EhCaBP2 are functionally
different. They bind different sets of E. histolytica pro-
teins in a Ca2-dependent manner. Activation of endoge-
nous kinase was also found to be unique for the two pro-
teins and the Ca2 concentration required for their
optimal functionality was also different. In addition, a
12-mer peptide was identified from a random peptide li-
brary that could differentially bind the two proteins. Our
data suggest that EhCaBP2 is a new member of a class of
E. histolytica calcium-binding proteins involved in a
novel calcium signal transduction pathway.
Ca2 is a ubiquitous second messenger involved in signal
transduction processes in eukaryotes (1). Intracellular Ca2
gradients initiate a number of cellular processes including cell
migration, exocytosis, activation of killer lymphocyte cells, cel-
lular secretion, transcellular ion transport, neurotransmitter
release, and gap junction regulation (2). These processes are
essentially mediated by a variety of Ca2-binding proteins
(CaBPs),1 which are involved in binding Ca2 and transducing
the signal through downstream effectors. Calmodulin (CaM), a
four EF-hand, highly conserved CaBP has been found in almost
all eukaryotic cells and has been implicated in a large number
of cellular processes (for review, see Ref. 3).
Ca2 signaling also plays a crucial role in pathogenesis of
many protozoan parasites (4). In Plasmodium, the expression
of CaM has been shown to be stage-specific and is involved in
erythrocyte invasion as well as schizont maturation (5). Che-
lation of Ca2 can prevent hepatocyte invasion by merozoites
(6). Ca2 is also involved in invasion of host cells by trypano-
somatids (7). Treatments that decrease or increase cytoplasmic
Ca2 modify Trypanosoma cruzi infectivity (8). Besides, Ca2
also regulates various other cellular processes, such as apopto-
sis, loss of motility, environmental sensing, and excystation (9,
10). In the protozoan parasite Entamoeba histolytica, the caus-
ative agent of amebiasis, Ca2 is reported to be involved in its
pathophysiology by initiating the amebic cytolytic activity (for
a recent review, see Ref. 11). Amebic cytolytic activity could be
blocked by Ca2 channel blockers, or by treatment with EGTA
(12), whereas stimulation of amebic PKC activity with phorbol
esters enhanced lysis of target epithelial cells (13). Changes in
the Ca2 profile were also related to the cell cycle and the
developmental stages of the parasite i.e. the cyst or the tropho-
zoite stage (14). Furthermore, extracellular Ca2, amebic in-
tracellular Ca2 flux, bepridil-sensitive Ca2 channels and a
putative CaM-dependent signal transduction pathway have
been implicated in the growth and encystation of Entamoeba
(15). Ca2 is thus speculated to play a direct role in precipitat-
ing the cytopathic effects of E. histolytica.
A number of CaBPs have been identified in E. histolytica (4).
Among these are two related EF-hand-containing proteins,
grainin 1 and 2, which are localized in intracellular granules (16).
They may be involved in phagocytosis, control of endocytotic
pathways and Ca2-dependent granular discharge. Another pro-
tein, URE3-BP, was shown to have a transcription regulatory
function with Ca2-dependent DNA binding properties (17, 18).
CaM-dependent secretion of collagenases from electron dense
granules has been demonstrated using Entamoeba lysate but a
direct evidence for the presence of CaM is still lacking (19, 20).
We had previously characterized a CaBP (EhCaBP1) from E.
histolytica (21, 22). EhCaBP1 has 134 amino acid residues with
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four canonical EF-hand Ca2 binding domains. Though this pro-
tein has some structural similarity with CaM, it is functionally
quite distinct (23). Inducible expression of EhCaBP1 antisense
RNA demonstrated its role in cellular proliferation (24, 25).
Structural studies on EhCaBP1 have revealed an organiza-
tion similar to CaM, having two independent globular domains
connected by a flexible linker. It consists of four canonical
EF-hands, a pair each in the N- and C-terminal domains. The
Ca2 binding loops in the protein consist of 12 contiguous
residues flanked by two helices, which are, oriented nearly
perpendicular to each other, a feature shared by other mem-
bers of the family of EF-hand proteins (26). EhCaBP1 is struc-
turally related to CaM and Troponin C (TnC) despite low se-
quence homology with these proteins. The major differences in
the structure of EhCaBP1 with respect to CaM and TnC are in
the Ca2 binding loops, interhelical angles and exposed hydro-
phobic surface. These differences have led to a more open
conformation for the Ca2 binding loops in the C-terminal
domain of EhCaBP1 compared with the ones in the N-terminal
domain and higher solvent exposure of the hydrophobic resi-
dues (27, 28). In EhCaBP1, the linker region exhibits a large
structural flexibility, leading to an ill-defined orientation of the
two domains (N- and C-terminal) with respect to each other.
These structural features make EhCaBP1 functionally distinct
from other CaM-like Ca2-binding proteins. In this study, we
report the identification and partial characterization of Eh-
CaBP2, a paralog of EhCaBP1, and show that these two pro-
teins are functionally distinct.
EXPERIMENTAL PROCEDURES
Strains and Cell Growth—E. histolytica strain HM1:IMSS was main-
tained at 36 °C in TYI-S-33 medium with appropriate antibiotics (29).
Southern and Northern Hybridization—Total DNA was purified
from late-log phase grown cells, as described earlier (30). Genomic
DNA, digested with appropriate restriction enzymes and separated on
an agarose gel, was transferred to nylon membranes. Southern blots
were hybridized in a solution containing 1% SDS, 1 M NaCl, and 3 105
cpm ml1 of DNA probe at 65 °C for 16 h. Blots were washed according
to the manufacturer’s instructions and exposed for autoradiography.
Radioactive DNA probes were prepared using the NEBlot random prim-
ing kit (NEB).
Total RNA was purified using TriPure reagent (Roche Applied Sci-
ence) according to the manufacturers’ instructions. RNA samples (30
g) were denatured by incubating with 6 M deionized glyoxal, 50% (v/v)
Me2SO and 1 gel running buffer (12 mM Tris-HCl, 6 mM sodium
acetate, and 0.3 M EDTA, pH 7.0) at 50 °C and electrophoresed in a 1.2%
(w/v) Tris acetate-EDTA (TAE) agarose gel. After electrophoresis, the
gel was blotted on to a GeneScreen plus (GS) nylon membrane (NEN),
and hybridization was carried out at 42 °C in 50% formamide-contain-
ing hybridization buffer according to the manufacturer’s instructions.
Polymerase Chain Reaction—Primers to amplify the EhCaBP2 ORF
were designed based on the Entamoeba GSS sequence data base. The
primers used (Primer 1: 5-GGGAAACATATGTCATTACAAAAGAT-
T-3 and Primer 2: 5-GGGAAAGGATCCTTAAAGATTGAATGC-3)
were obtained from Microsynth, Switzerland. PCR was performed with
400 ng of E. histolytica genomic DNA. The conditions were: 92 °C, 5
min; 36 °C, 1 min; 70 °C, 1 min (5 cycles); 92 °C, 1 min; 56 °C, 1 min;
70 °C, 1 min (25 cycles). The PCR products were cloned in pGEMTeasy
vector (Promega) and subsequently in pET30a vector (Novagen) for
expression in E. coli BL21 (DE3) cells.
The primer set 3–4 was used to amplify reverse-transcribed products
obtained from total HM1:IMSS RNA (primer 3: 5-GTTCAAGTATAA-
ATTCATTACAAAAGATT-3; Primer 4: 5-GTTCTTTAACAGCAGCTG-
CA-3). The conditions used were 92 °C, 1 min; 48 °C, 1 min; 70 °C, 1
min (30 cycles).
Expression and Purification of Recombinant EhCaBP2 in E. coli—
The purification of recombinant EhCaBP2 was carried out essentially
as described earlier (22). Induced bacterial cells were resuspended in 50
mM Tris, pH 7.5 and 2 mM EGTA and lysed by freeze-thaw followed by
sonication. Heat treatment of the lysed cells was carried out by incu-
bation in a boiling water bath for 3 min followed by separation of
heat-precipitable E. coli cellular proteins. The supernatant, containing
recombinant EhCaBP2, was purified using ion-exchange chromatogra-
phy employing methods described earlier (22). The Ca2-free EhCaBP2
was prepared with the help of Chelex 100 as described (31).
Affinity Purification of EhCaBP-binding Proteins—The EhCaBP-
binding proteins were purified using the respective EhCaBP-Sepharose
affinity chromatography as described before (23). The soluble cytoplas-
mic fraction was first diluted in Buffer C (20 mM Tris-Cl, pH 7.5, 1 mM
imidazole, 1 mM magnesium acetate, 1 mM CaCl2, 2 mM -mercaptoeth-
anol) and passed through EhCaBP-Sepharose 4B column (4–6 mg of
protein per ml of bed volume). Unbound proteins were washed with 10
bed volumes of Buffer C. The bound proteins were eluted with Buffer D
(same as Buffer C except that CaCl2 is replaced with 2 mM EGTA) as
1-ml fractions. The chromatographic steps were carried out at 4 °C. The
eluates were dialyzed against water and then concentrated by centrif-
ugal evaporation.
Laser Ionization Time of Flight Mass Spectrometry (MALDI-TOF)—
MALDI-TOF spectrometry was used to analyze EhCaBP-binding pro-
teins. The matrix was prepared using sinapinic acid in 30% (v/v) ace-
tonitrile, and 0.33% trichloroacetic acid, and the samples were analyzed
by a MALDI-TOF spectrometer (Kratos PCKOMPACT SEQ model).
The mass calibration was carried out using the MS-CAL1 mass calibra-
tion kit for MALDI-MS (Sigma).
In Vitro Kinase Assay—Total Entamoeba cell extract was prepared
and the activity of Ca2-dependent kinases was estimated according to
Chandok and Sopory (30). The reaction mixture contained 30 mM
HEPES, pH 7.5, 5 mM MgCl2, 40 g of histone (Type IIIS, Sigma), 30 g
of E. histolytica cell extract, protease inhibitor mixture, CaCl2 or EGTA,
and 100 pmol of peptide where indicated. The reaction volume was
adjusted to 50 l. The reaction was initiated by adding 100 M
[-32P]rATP (specific activity 5000 Ci/mmol, Amersham Biosciences)
and allowed to proceed at 30 °C for 10 min. The reaction was terminated
by adding 10% trichloroacetic acid, which precipitated total protein in
the reaction mixture. The pellet was washed with diethyl ether/ethanol
(1:1) mixture and after drying the pellet, and spotting the rehydrated
pellet on GF/C paper, the amount of radioactivity was determined in a
scintillation counter. For visualization of phosphorylated products, the
reaction mixture after termination was separated in a 10% SDS-PAGE.
The fluorographed gels were dried and exposed to an x-ray film. In
competition experiments involving peptides, reactions were performed
under identical conditions using E. histolytica total cell lysate preincu-
bated with indicated amounts of peptide(s).
Ca2-dependent Phage ELISA—Phages were prepared according to
standard procedures and phage ELISA assays were performed essentially
as described earlier (32). However, certain changes were introduced to
ensure that the phage binding was Ca2-dependent. The phages were
allowed to bind to the EhCaBPs in the presence of 2 mM CaCl2. The plates
were washed in TBST containing either 2 mM CaCl2 or 4 mM EGTA, and
the bound phages were detected using horseradish peroxidase-labeled
anti-M13 monoclonal antibody (Amersham Biosciences; 1:3000 dilution)
with TMB substrate (Amersham Biosciences) at 410 nm.
Surface Plasmon Resonance Analysis—Binding kinetics of phages to
protein was determined using IAsys Auto (Affinity sensor). Amplified
phages (1011 pfu/ml) from a 20-ml culture were precipitated and dis-
solved in 50 l of phosphate-buffered saline, pH 7.4. Phages were
biotinylated using established protocols (33). Biotinylated phages were
immobilized onto streptavidin bound on a biotin-coated surface. For
determination of association rate constants, EhCaBPs (25–400 M) in
the binding buffer (10 mM Tris, pH 7.5, 150 mM NaCl, 2 mM CaCl2) were
used. Following analyte binding, dissociation rate constants were meas-
ured by replacing the sample with binding buffer. The surface was
regenerated with the regeneration buffer (10 mM Tris, pH 7.5, 150 mM
NaCl, 4 mM EGTA). Kinetics of the interaction of EhCaBPs with phages
were analyzed by non-linear regression using FASTfit software package
supplied with IAsys instrument.
Sequence Analysis—Preliminary sequence data for E. histolytica is
deposited regularly into the GSS division of GenBankTM and was used
for this analysis. The sequencing effort is part of the International
Entamoeba Genome Sequencing Project and is supported by award
from the National Institute of Allergy and Infectious Diseases, National
Institutes of Health.
The Entamoeba genome sequence data base from the Sanger Centre
(www.sanger.ac.uk) supported by the Welcome trust was also used.
BLAST searches (NCBI: www.ncbi.nlm.nih.gov/BLAST) were used for
finding homologues of EhCaBPs. ClustalW (EMBL: www.ebi.ac.uk) was
used for alignment of multiple sequences.
Molecular Modeling—Molecular modeling was carried out using the
Modeler (34) interface of INSIGHTII (Molecular Simulations Inc.) The
model was built on the basis of the NMR solution structure (1JFK) of
the Ca2-bound form of EhCaBP1 (28). The constructed model was
EhCaBP2 of E. histolytica 12899
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minimized initially with full backbone constraints, which were gradu-
ally relaxed as the minimization proceeded. The final model was vali-
dated by PROCHECK (35).
Molecular dynamics simulation was carried out to explore the con-
formational variation existing in the flexible linker region between the
two domains in EhCaBP1 and EhCaBP2. 10 ps of equilibration at 300
K were followed by 100 ps of molecular dynamics (MD) simulation. The
MD simulation was carried out for the 13 residues of the linker region
with maximum variability, while the rest of the structure was con-
strained. RMSD for 10 representative MD-derived structures of the
linker region (residues 55–67) was found to be 0.32 Å suggesting no
significant variation from the average structure.
Circular Dichroism Spectroscopy—CD measurements were per-
formed using a Jasco-810 spectropolarimeter. Each spectrum was
measured in the far-UV region (200–270 nm) and was an average of five
scans. Scans were done at a protein concentration of 1 M using a
cuvette of pathlength 1 cm. Percentage helical content was calculated
using the method described by Barrow et al. (36).
Miscellaneous Methods—The concentration of protein in a sample
was estimated by bicinchoninic acid assay using bovine serum albu-
min (BSA) as a standard (37). Sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE) analysis was carried out in 10 or 14%
acrylamide gels, as indicated, under reducing conditions according to
Laemmli (38). Following electrophoresis, the gels were subjected to
fluorography as described by Laskey and Mills (39). Peptides (Peptide
C61, pC61:GAWYPREASTAS; Peptide C112, pC112: SMNLQTP-
GYKDG, Control 12-mer peptide, p12: YIPQPRPPHPGL) were syn-
thesized. Peptides were desalted and purified by reverse-phase HPLC
using a C18 column and their amino acid sequence confirmed.
RESULTS
A Second E. histolytica Calcium-binding
Protein (EhCaBP2)
Our laboratory had previously characterized a calcium-bind-
ing protein, EhCaBP, from E. histolytica (21). A search for the
FIG. 1. Sequence analysis of Eh-
CaBP2. Panel A, alignment of nucleotide
sequences of EhCaBP1 (Sanger contig
3894) and EhCaBP2 (Sanger contig 4494)
using ClustalW. The beginning and the
end of the ORFs are marked by arrows.
The start (ATG) and the stop (TAA)
codons are highlighted. Dashed lines indi-
cate introduction of gaps to maintain op-
timal alignment. Panel B, alignment of
amino acid sequences of EhCaBP1 and
EhCaBP2. The dashed lines represent
identical amino acids and the canonical
EF-hand domains (I to IV) are marked in
boxes.
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presence of EhCaBP homologs in the E. histolytica genome
sequence data base at NCBI revealed (in addition to an entry
with complete match with EhCaBP) a sequence that showed a
very high score and low p value (score  163; p  4e38) using
BLAST. The identified sequence was then used to find a contig
that carried the entire coding region, from the genome data
base at the Sanger Centre, UK (contig 4494). The second gene
was designated as EhCaBP2 whereas the original gene was
renamed EhCaBP1.
The overall identity at the nucleotide level between Eh-
CaBP2 and EhCaBP1 was 79% (Fig. 1A). Of the 80 nucleotides
that differed in the two genes, 28 were in the third codon
position, leaving the encoded amino acids unchanged. The con-
ceptual translation product of EhCaBP2 was compared with
EhCaBP1 and the alignment of the two sequences is shown in
Fig. 1B. The amino acid sequences of the two proteins showed
an identity of 78%. Both the proteins have four typical EF-hand
Ca2 binding domains. The level of similarity between the two
proteins varied along the length of the sequence. The maximum
identity was observed in the Ca2 binding domains with a total
of 6 amino acid substitutions (Fig. 1B). The minimum identity
was seen in the 27 amino acid central linker region between
Ca2 binding domains 2 and 3, which had 10 substitutions. The
sequence comparison shows that the overall structure of both
the proteins is similar, but the two may perform different
functions due to variations in the central linker.
The nucleotide sequences upstream and downstream of the
ORF of EhCaBP1 and EhCaBP2 showed no significant se-
quence identity (Fig. 1A). In addition, genes present in the
vicinity of each EhCaBP were different. The putative ORF
located upstream of EhCaBP1 was the human homolog of
AMP-deaminase (Score  72, p  2e12) whereas the ORF
upstream of EhCaBP2 had similarity to myosin heavy chain
(Score 56, p 3e7). Therefore, these two EhCaBP genes are
unlikely to be allelic copies.
Currently, genomic sequences from different species of En-
tamoeba are being deposited in the GSS databases maintained
at the Sanger Centre. The putative coding regions of several
EhCaBP-like sequences were identified from this data base
using standard bioinformatics tools. A CaM-like protein dis-
playing 50–78% identity to other calmodulins was also identi-
fied in this data base (contig 5693). A phylogenetic analysis of
the EhCaBPs and related orthologs and paralogs and different
calmodulins revealed that all Entamoeba CaBPs are distinctly
different from CaMs including that from E. histolytica (Fig. 2).
A close examination of the tree revealed minor differences
among the CaBPs from different Entamoeba species. Among
the Entamoeba CaBP orthologs, E. invadens displayed the
maximum divergence. None of the EhCaBP-like Entamoeba
CaBPs is close to CaM as the two segregate out in different
clusters. The groupings were well supported by high bootstrap
values. Interestingly, none of the sequences were found more
than once in the data base, which may imply all of these
isoforms may not be duplicated pseudogenes. From this anal-
ysis, it appears that EhCaBP1 and EhCaBP2 are paralogs of
each other as they branched out separately.
FIG. 2. Phylogenetic analysis of Eh-
CaBPs. The tree was constructed on the
basis of the alignment generated using
ClustalW with manual editing. Dayhoff’s
amino acid matrix program was used for
generating the tree. Bootstrap values are
indicated at each branch point.
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Copy Number of EhCaBP2
To determine the copy number of EhCaBP2, E. histolytica
genomic DNA was digested with the restriction enzymes BglII
and EcoRI. From the nucleotide sequence of EhCaBP2, it was
determined that BglII does not have a site in the coding region
whereas EcoRI has a single site. Genomic DNA digested with
these enzymes was blotted and hybridized with EhCaBP2
probe. The EcoRI-digested DNA hybridized to two bands of
sizes 6.0 kb and 4.36 kb while BglII-digested DNA hybridized
with a single band of 4.36 kb (Fig 3B). Under the conditions of
hybridization, the EhCaBP2 coding region probe specifically
hybridized to EhCaBP2 DNA and not EhCaBP1 DNA (Fig. 3C).
The sizes of bands obtained by Southern hybridization matched
very well with the expected sizes from nucleotide sequence of
the 18-kb TIGR contig 318109, which contains the EhCaBP2
ORF (Fig. 3A). The Southern data show that EhCaBP2 is a
single copy gene.
Expression of EhCaBP2 in E. histolytica HM-1:IMSS
Expression of EhCaBP2 was checked in order to rule out the
possibility that it could be a pseudogene. A search of the data
base revealed an EST (accession no. AB002775) with 100%
identity with EhCaBP2 at the nucleotide level, suggesting that
this gene may be expressed in E. histolytica trophozoites (40).
The presence of EhCaBP2 transcript was confirmed using both
RT-PCR and Northern hybridization. EhCaBP2-specific prim-
ers were designed from the regions that showed maximum
variability with respect to EhCaBP1 (marked in Fig 4A, top
panel). The specificity of the primers was checked by a PCR
reaction using cloned EhCaBP1 and EhCaBP2 genes as tem-
plates (Fig. 4A, lanes 1 and 2). A band of 225 bp was detected
after RT-PCR of RNA isolated from axenic trophozoites (Fig.
4A, lane 3). In the absence of reverse transcriptase (Fig. 4A,
lane 4), no such amplification was detected, showing the ab-
sence of any contaminating DNA.
In addition, Northern hybridization of total HM1:IMSS RNA,
carried out at high stringency as described under “Experimental
Procedures,” revealed a single species of RNA transcript of 0.57
kb (Fig. 4B). Under the conditions used, the EhCaBP2 probe did
not hybridize with EhCaBP1 (Fig. 4B, inset a). The data indicate
that EhCaBP2 is expressed in E. histolytica.
Ca2 Binding Properties of Recombinant EhCaBP2
The EhCaBP2 ORF (402 bp) from strain HM-1:IMSS was
amplified using primers 1–2 designed from the GSS entry
AZ542766. The PCR-amplified product was cloned into the
expression vector pET30a as described under “Experimental
Procedures.” The recombinant protein was purified from the
induced bacterial lysate (data not shown) using a method de-
veloped for purification of recombinant EhCaBP1 (22). The
Ca2-free form of the protein was used for all experiments
involving Ca2 binding which was evaluated by CD spectros-
copy. CD studies were carried out on both holo and apo forms of
EhCaBP2. The CD profiles of the two protein forms showed
FIG. 3. Southern blot analysis of Eh-
CaBP2. Panel A, schematic representa-
tion of the positions of EcoRI and BglII
sites located on contig 318109 (TIGR data
base). The position of the EhCaBP2 ORF
is marked by a closed box. The scale (1 kb)
is indicated. Panel B, 1 g of genomic
DNA from E. histolytica HM-1:IMSS was
digested with indicated restriction en-
zymes, separated in a 0.8% agarose gel at
4 V/cm and hybridized with EhCaBP2
ORF as described under “Experimental
Procedures.” Panel C, Southern hybrid-
ization of cloned EhCaBPs with the radio-
labeled EhCaBP2 probe was carried out
as described for panel B. The plasmid
DNAs were first separated in 0.8% agar-
ose gel before transfer and hybridization.
Lane 1, EhCaBP1; lane 2, EhCaBP2.
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significant differences, which could be directly attributed to
conformational differences. Thus, a distinct conformational
change, evident in terms of the increase in the helical content,
was observed in the holo-EhCaBP2 as compared with the ap-
oprotein (Fig. 5). The helical content in the case of holo-Eh-
CaBP2 was about 56% and that in the case of the apoprotein
was found to be 35%. A similar trend was also reported earlier
with regard to the helical contents of the apo- and the holo-
EhCaBP1 (31).
Structural Model of EhCaBP2
A model for EhCaBP2 was built using methods described
under “Experimental Procedures.” (34). A comparative study of
the two proteins was done at the primary as well as the tertiary
level. The high sequence homology of the two proteins, Eh-
CaBP1 and EhCaBP2 was reflected in similar structural topol-
ogies for the two proteins namely, the basic tertiary structure
of two globular domains with the four well-conserved EF-hands
(Fig. 6a). The Ca2 binding domains show high degree of struc-
tural similarity between the two EhCaBPs. Residues responsi-
ble for Ca2 binding in EhCaBP1 were mapped using CON-
TACT (CCP4 Suite); only one residue, Ala16, in the Ca2
binding site of EhCaBP1 was found to be mutated to Ser16 in
EhCaBP2. However, significant differences were seen in the
flexible linker region. A reduction in helicity, leading to a more
compact structure in the EhCaBP2 linker region was evident,
with its helix being four residues shorter than that of Eh-
CaBP1. The resultant structural compaction might be due to
the absence of several bulky side chains in the linker region of
EhCaBP2. Charge differences also exist between EhCaBP1 and
EhCaBP2 (Fig. 6, b–e); the surface of EhCaBP1 is more posi-
tively charged compared with that of EhCaBP2. Due to the
compact packing within the EhCaBP2 linker region (Fig. 6a)
K74, which is a major component of a positively charged patch
in EhCaBP1 gets buried in EhCaBP2 by E67 (Gly67 in Eh-
CaBP1). Lys28 and Arg30, which are located on the surface of
EhCaBP1, contributing to a significant positively charged
patch, are changed to Ser28 and Pro30 in EhCaBP2 leading to
significant reduction in the positive charge on the surface. The
CD spectra also showed that the Ca2-bound form of EhCaBP2
exists in a largely helical conformation (Fig. 5).
Functional Analysis of EhCaBP2
Analysis of Binding Proteins—The purified EhCaBP1- and
EhCaBP2-binding proteins were analyzed by MALDI/TOF
FIG. 5. CD Spectrum of EhCaBP2. The CD profile of EhCaBP2 was
obtained in aqueous buffer. The thick continuous line represents the
profile for the holo and dotted discontinuous line is that of the calcium-
free apo protein.
FIG. 4. Expression of EhCaBP2 RNA
in E. histolytica. Panel A, amplification
of EhCaBP2 RNA by RT-PCR. The loca-
tion of the primers is indicated with ar-
rows at the top of the figure. The positions
of the calcium binding domains are
marked I-IV in this scheme. The specific-
ity of the primers for EhCaBP2 was
checked by PCR amplification of Eh-
CaBP1 and EhCaBP2-containing plasmid
templates. The PCR products were elec-
trophoresed in 1.2% agarose gel at 4
V/cm. Lane 1, EhCaBP2 plasmid DNA;
lane 2, EhCaBP1 plasmid DNA; lane 3,
total HM1:IMSS RNA and lane 4, same as
lane 3 except no reverse transcriptase
was added. Panel B, Northern blot anal-
ysis of EhCaBP2. 30 g of purified total
RNA was separated in a 1.2% denaturing
formaldehyde agarose gel and transferred
onto a nylon membrane. The blot was hy-
bridized with a radiolabeled EhCaBP2
coding region probe as described under
“Experimental Procedures.” Inset a, the
probe was also hybridized with plasmid
DNA (5 ng) containing cloned insert un-
der the same condition. 1, EhCaBP2 and
2, EhCaBP1.
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mass spectrometer. The spectrum differed considerably for
the two sets of binding proteins (Fig. 7). Whereas there was
essentially a single major species of 95 kDa among the Eh-
CaBP2-binding proteins, a number of polypeptides were ob-
served among EhCaBP1-binding proteins. No common peak
was observed in both the spectra suggesting that the two
proteins bind different targets. Mass spectrometric pattern of
binding proteins was found to be somewhat different from
that obtained by SDS-PAGE analysis of [35S]methionine-la-
beled binding proteins prepared in the same way (data not
shown here). It may be due to uneven labeling of proteins
with [35S]methionine independent of size or relative amount
or lack of effective separation at high molecular weight range
in SDS-PAGE.
Activation of Endogenous Kinase—EhCaBP1 was shown to
activate endogenous kinase(s) that may be an important com-
ponent of the Ca2-signal transduction pathway mediated by
this protein (23). The ability of EhCaBP2 to activate an endog-
enous kinase was similarly tested. The in vitro system for
assaying kinase activity included E. histolytica cell lysate as
the source of kinase, and histone as the substrate. The reaction
was carried out in the presence of 10 and 100 M Ca2 with
varying concentrations of EhCaBP2 (Fig. 8B). The two Ca2
concentrations were chosen on the basis of our previous work
where two Ca2-dependent kinase activities were found in the
amebic lysate, with optimum activation at 10 and 100 M added
Ca2 respectively (23). The data showed that, indeed, Eh-
CaBP2 could also activate an endogenous kinase in the pres-
ence of 100 M added Ca2 and at 2 nM protein concentration.
In contrast, EhCaBP1-dependent kinase activity was optimal
at 10 M added Ca2 as reported earlier (Fig. 8A). Therefore,
these two proteins differ in the Ca2 concentrations required
for optimal activity.
In order to identify the endogenous substrate of Ca2/Eh-
CaBP2-dependent kinase, a phosphorylation assay was per-
formed in the absence of any exogenous acceptor, and the
products were separated by SDS-PAGE. The result was com-
pared with that obtained with EhCaBP1 to see if the two
FIG. 6. Comparative modeling of
EhCaBP2. Stereoscopic representation
showing residues mutated in CaBP2 with
respect to CaBP1. Panel a, unrelated
amino acid replacements are indicated in
red. Mutations to similar amino acids are
shown in blue. The surface features of
EhCaBP1, front (panel b) and back view
(panel c) have been compared with those
of EhCaBP2, front (panel d) and back
view (panel e). The solvent accessible sur-
faces of the proteins have been color coded
according to charge: red negative and blue
positive.
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proteins share the same substrate. Both these proteins were
found to stimulate phosphorylation of a 47 kDa protein present
in the cell-free lysate of E. histolytica (Fig. 8C). However, the
extent of phosphorylation by EhCaBP2 was at least 20 times
more than that by EhCaBP1 under identical experimental con-
ditions (Fig. 8C). The relative ability of the two EhCaBP-de-
pendent kinases to phosphorylate histone or endogenous
polypeptide as substrates differed significantly and may be due
to their relative affinities for the different substrates. The
phosphorylated band in the case of EhCaBP2 was diffuse sug-
gesting that the level of phosphorylation and or glycosylation
may also be different giving rise to a heterogeneous band.
In order to infer whether the two EhCaBPs bind to different
sets of target proteins the E. histolytica lysate was first de-
pleted of EhCaBP2-binding proteins by incubating with Eh-
CaBP2-Sepharose. This was used to assay for both EhCaBP-
dependent kinases. After depletion there was very low
endogenous EhCaBP-dependent kinase activity. On addition of
EhCaBP1 to depleted lysate the level of activation was found to
be nearly at the same level as that obtained with normal lysate
(Fig. 9, lanes 3 and 5). However, the level of activation of
EhCaBP2-dependent kinase activity in depleted lysate was
about 50% compared with that of 300% when normal lysate
was used as a source of kinase (Fig. 9, lanes 6 and 7). The
results suggest EhCaBP2-Sepharose could deplete specifically
the kinase activated by it but not that activated by EhCaBP1.
FIG. 7. MALDI-TOF mass spectrometric analysis of EhCaBP-binding proteins. The binding proteins were purified using affinity
chromatography over respective EhCaBP-Sepharose matrix as described in the text. The proteins eluted in the presence of EGTA were dialyzed
against water and then concentrated before mass spectrometric analysis. MALDI spectrum of EhCaBP1-binding proteins (A) and EhCaBP2-
binding proteins (B).
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Therefore it appears that the two kinases may be distinctly
different from each other.
Peptide C112 Binds EhCaBP2 Specifically—The two Eh-
CaBPs were further distinguished on the basis of their binding
to a dodecamer peptide, C112 (SMNLQTPGYKDG). This pep-
tide was identified from a random dodecamer peptide phage
display library by affinity purification using an EhCaBP-
Sepharose column.2 Phage-displayed peptides obtained from
the above screen were tested for their differential binding to
the two EhCaBPs. Binding was assayed using Ca2-dependent
phage ELISA as described under “Experimental Procedures.”
The phage-displayed peptide C112 showed at least 5-fold
higher Ca2-dependent binding to EhCaBP2 compared with
EhCaBP1 (Fig. 10).
The extent of phage 112 binding to EhCaBP1 was negligible
as the value was close to that obtained in the presence of
EGTA. The parental M13 phage showed no significant binding.
To check for nonspecific binding, bovine serum albumin was
used for coating the ELISA plates instead of EhCaBP. The level
of nonspecific binding was low (about 5% of specific binding).
The binding of phage C112 to both the EhCaBPs was also
checked by a real-time assay employing surface plasmon reso-
nance. Using binding conditions as described under “Experi-
mental Procedures,” the affinity constant was found to be 14 M
for EhCaBP2 (Fig. 11). No binding was observed with Eh-
CaBP1 under identical binding conditions, demonstrating the
specificity of phage C112 for EhCaBP2.
The binding of the synthetic peptide C112 to EhCaBP2 also
blocked activation of endogenous kinase by EhCaBP2. In the
presence of 100 pmole pC112, the inhibition was found to be
about 85% of the EhCaBP2-dependent kinase activity (Fig. 12).
No such inhibition was obtained when other 12-mer peptides,
p12 and p61, were used in the kinase activation assay. This
further demonstrates that the two EhCaBPs are functionally and
structurally distinct. The sequence of C112 was used to search
the Entamoeba genome data base at both Sanger Center and
TIGR. None of the hit sequences obtained had a perfect match.
The best match was 7 of 12 amino acids (data not shown).
DISCUSSION
EhCaBP1 is the first CaM-like calcium-binding protein that
has been identified and characterized from E. histolytica. There
2 P. Chakrabarty, D. K. Sethi, K. J. Kaur, D. M. Salunke, S.
Bhattacharya, and A. Bhattacharya, manuscript in preparation.
FIG. 8. Stimulation of E. histolytica protein kinase by EhCaBP.
E. histolytica cell-free lysate (30 g) was used as the source of the
kinase and histone type III (40 g) as the substrate. The amount of
EhCaBP is 2 nM, unless otherwise indicated. The concentration of Ca2
used in the experiments is indicated. EGTA was used at 500 M. The
assay was performed as described under “Experimental Procedures”
using [-32P]ATP as the phosphate donor. The amount of radioactivity
incorporated into histone was determined either by PhosphorImager
(Fuji BAS 800) analysis of 10% SDS-PAGE-separated phosphorylated
products (panel A) or by scintillation counting of total trichloroacetic
acid-precipitable proteins (panel B). Endogenous substrate phosphoryl-
ation by EhCaBP-dependent protein kinase. was performed with cell-
free E. histolytica lysate (30 g) and 2 nM each of EhCaBP1 (lanes 2–5)
or EhCaBP2 (lanes 6–9) in the presence of 100 M added Ca2 (lanes 2
and 3 and lanes 6 and 7) or 500 M EGTA (lanes 4 and 5 and lanes 8 and
9) as described earlier, except that histone was not added in the reaction
mixture, lane 1 did not have Entamoeba cell lysate but contained Ca2
(panel C). The phosphorylated reaction mixes were visualized after
separation on a 10% SDS-PAGE followed by autoradiography.
FIG. 9. Depletion of EhCaBP2-dependent kinase activity by
EhCaBP2-Sepharose. E. histolytica cell-free lysate was incubated
with EhCaBP2-Sepharose in the presence of 100 M Ca2 at 4 °C for
1 h, and the supernatant is referred to as a depleted source of protein
kinase. Equal amounts (30 g) of depleted lysate and normal unde-
pleted lysate was used for checking the efficacy of either EhCaBP2- or
EhCaBP1-dependent protein kinase activity. The respective EhCaBPs
were used at 2 nM concentration. The amount of radioactivity incorpo-
rated into histone was determined by PhosphorImager analysis (Fuji
BAS 800) of 10% SDS-PAGE-separated phosphorylated products. Rep-
resentative bands obtained by autoradiographic exposure are shown.
FIG. 10. Binding of C112 phage to EhCaBP2 and EhCaBP1.
Indicated amounts of phage C112 were allowed to bind to 4 g each of
EhCaBP2 or EhCaBP1 immobilized on an ELISA plate. Binding assay
was carried out in the presence of Ca2 (2 mM) or EGTA (4 mM) as
described under “Experimental Procedures.” Bound phages were de-
tected immunologically by incubating each well with HRPO-tagged anti
M13 antibody. The plate-bound HRPO was detected with TMB sub-
strate and absorbance recorded at 410 nm. --, EhCaBP2/Ca2; -▫-,
EhCaBP2/EGTA; -‚-, EhCaBP1/Ca2 and , EhCaBP1/EGTA.
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appears to be a CaM gene encoded in the genome of E. histo-
lytica as inferred by sequence similarity and phylogenetic re-
lationship (Fig. 2). The expression of this gene and functional
analysis of the gene product has not been studied so far though
work done several years ago indicated presence of CaM-like
activity in this organism (19, 20, 23). EhCaBP was originally
thought to be a form of primitive CaM. However, phylogenetic
analysis and structure modeling studies described in this re-
port and some of the experimental observations reported ear-
lier, clearly show that the EhCaBPs are distinctly different
from CaM (23). Both the EhCaBPs are phylogenetically close to
each other and may have been derived by a duplication event.
Many CaBPs are known to be present in multiple copies
(isoforms) in different organisms. Among these, CaM and CaM-
like proteins have been studied quite extensively (41, 42, 43).
One such CaM isoform, the epithelial cell protein CLP, has the
same size and displays 85% sequence identity with CaM (41).
Both CaM and CLP can activate CaM kinase II. However, CLP
cannot activate four other CaM-dependent enzymes. In plants,
soybean has four different CaM variants. Of these, SCaM4
shows the highest divergence at the level of amino acid se-
quence (44). Unlike SCaM1, SCaM4 did not activate NAD
kinase, indicating subtle variations at the functional level that
may be due to variations at the primary sequence level. Sup-
port for this comes from a study where a number of different
single mutations in CaM (e.g. phenylalanine to alanine) altered
its properties and the different mutants displayed distinctive
functional defects (45). In addition, a number of single amino
acid mutations in Paramecium CaM that did not alter growth
properties, did however, display behavioral aberrations (46).
Thus, changes in the protein interaction domain, without
changing the rest of the protein can, in principle, alter the
specificities of proteins. The human genome also contains a
family of non-allelic CaM genes that are under selective pres-
sure to encode identical proteins, while maintaining divergent
nucleotide sequences of non-coding regions (43). Preserving
multiple CaM genes with divergent non-coding sequences may
be necessary in complex organisms to ensure that the many
CaM-dependent processes occur with appropriate spatial and
temporal control (43). Two or more non-allelic CaM or CaM-like
genes have also been reported in Xenopus (47) and trypano-
somes (48). Therefore it is not surprising that there are multi-
ple forms of EhCaBP. The length and composition of the central
linker region has been shown to be important for maintaining
the functionality of CaM. Apart from binding to target peptide
stretches, the linker has also been proposed to modulate metal
ion binding and interdomain cooperativity (49). The major se-
quence divergence between the EhCaBPs, interestingly, spans
this region, which suggests distinct functional roles for the two
proteins. These molecules interacting with specific sets of tar-
get proteins may initiate different downstream pathways. This
is evident from some of the results presented here that show
different sets of binding proteins as revealed by affinity puri-
fication and subsequent analysis using MALDI-TOF mass
spectrometry and the ability of the EhCaBP2 affinity matrix to
deplete only EhCaBP2-dependent kinase activity but not Eh-
CaBP1-dependent activity. Differences in the phosphorylation
FIG. 11. Surface plasmon resonance analysis of binding of
phages to EhCaBP. Biotinylated phages C112 (1010 phages) were
allowed to bind uniformly to a streptavidin-coated cuvette. The cuvette
was primed with the binding buffer (TBS containing 2 mM Ca2) to
achieve a constant baseline. Different concentrations of EhCaBP2 pro-
tein prepared in the binding buffer were allowed to pass through the
cuvette. Typical binding time allowed was 3–5 min. Dissociation was
done using the binding buffer typically for 10 min. In certain cases,
regeneration was done using TBS containing 4 mM EGTA until the
baseline was achieved. Association and dissociation is represented as
linear fit of the kon with the protein concentration. The scales of the x-
and y-axes are in molar (M) and s1, respectively.
FIG. 12. Inhibition of EhCaBP-dependent activation of protein
kinase by peptide. EhCaBP2- and EhCaBP1-stimulated protein ki-
nase(s) was assayed using E. histolytica total cell-free lysate (30 g) as the
source of the kinase and histone type III (40 g) as the substrate as
described under “Experimental Procedures.” The individual peptides
were added to a final concentration of 100 pmol. The amount of Ca2 used
for EhCaBP2 and EhCaBP1-dependent kinase assays are 100 and 10 M
respectively. The amount of radioactivity incorporated into histone was
determined by PhosphorImager analysis (Fuji BAS 800) of 10% SDS-
PAGE-separated phosphorylated products. The corresponding autoradio-
graphic signals are shown at the bottom of the panels. Panel A, EhCaBP2-
dependent; panel B, EhCaBP1-dependent phosphorylation.
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patterns of the endogenous substrates by EhCaBP1 and Eh-
CaBP2-dependent protein kinase(s) also indicate distinct func-
tional pathways for these two closely related proteins.
The data presented here show that EhCaBP1 and EhCaBP2
are non-allelic variants with identical sizes and a high degree
of identity at both nucleotide and amino acid sequence level.
Since the upstream and downstream sequences flanking the
coding regions are totally different, it is likely that the two
EhCaBPs are located in different chromosomal regions. It is
unlikely that there are other members of this family, since a
search of the genome data base available as of now did not
reveal any other isoforms.
Commensurate with the observed biochemical properties of
the two proteins, the surface features in the two proteins show
differences based on modeling studies. In general no difference
was found in the regions that bind Ca2 in these two proteins.
The central linker region, connecting the two globular domains
in CaM-like proteins has been a region of special interest for
biochemists and structural biologists alike. Several site-di-
rected mutageneses have been carried out in these proteins to
understand the effect of length and composition of this linker
on their individual functions (50, 51, 52). The flexible linker
region between the two domains may contribute to the different
juxtapositions of the Ca2 binding domains. The presence of
Gly63 and Gly67 in the linker region of EhCaBP1 was shown to
be important for the function of EhCaBP1 as it provided flex-
ibility to the region (26, 28). In one of the earlier studies on
EhCaBP, these two Gly residues were mutated to Ala (53).
Such mutations were found to impart rigidity to the flexible
linker region. Circular dichroism and mass spectrometric tech-
niques were also used to reveal that the mutant protein was
weakened in its ability to bind Ca2 and its target peptides
(53), implying a possible role of these glycines in specific inter-
actions with target peptides. In EhCaBP2, Gly63 and Gly67
have been changed to Ala63 and Glu67, respectively. These
changes along with charge differences are likely to affect the
specificity of binding of the target proteins leading to altered
functional properties. The identification of a peptide C112 that
can bind EhCaBP2 selectively suggested distinctive specificity
of target protein interaction by the two EhCaBPs. Though
C112 has been identified from a pool of random peptides and
not from a biological source, the selective binding indicates
differences in the binding pocket between the two EhCaBPs.
The inhibition of endogenous kinase showed that the binding of
the peptide C112 to EhCaBP2 is biologically relevant as the
binding data correlated with functional inhibition data. All
these suggest that the two EhCaBPs are functionally distinct.
The signal transduction pathways involving both the Eh-
CaBPs are currently being worked out. It will be interesting to
see if there is any cross-talk or redundancy between the two
pathways. To determine the cellular role of these two proteins,
we are also planning to design specific inhibitors for both the
EhCaBPs that will help elucidate the role of these two proteins
in vivo.
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